Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer

Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer

Aim: To investigate the prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer. Patients and Methods: A total of forty-nine male patients aged between 42 and 84 years with advanced prostate cancer receiving therapy of maximum androgen blo...

Full description

Bibliographic Details
Main Authors:	A E Aghaji, J O Ohaju-Obodo, D N Osegbe, H N Mbibu, H Maitama
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2005-01-01
Series:	International Journal of Medicine and Health Development
Subjects:	advanced prostate cancer prostate specific antigen (psa) rate of change of psa prognostic significance
Online Access:	http://www.ijmhdev.com/article.asp?issn=2635-3695;year=2005;volume=10;issue=1;spage=53;epage=57;aulast=Aghaji;type=0

Similar Items

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-03-01)

SIGNIFICANCE OF DETECTION OF FREE/TOTAL PSA RATIO AND OTHER BIOCHEMICAL PARAMETERS IN PATIENTS WITH BPH, CARCINOMA PROSTATE AND ITS CLINICOPATHOLOGIC CORRELATION
by: S. Joshi, et al.
Published: (2021-11-01)

Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-08-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
by: Murat Zor, et al.
Published: (2018-12-01)

The effect of green tea on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials
by: Elham Sharifi-Zahabi, et al.
Published: (2021-03-01)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
by: Govinda Nanjaiah Laxmana Raju, et al.
Published: (2023-06-01)

Clinical application of p2PSA and its derivatives (%p2PSA and Phi) in the diagnosis of prostate cancer
by: Weiwang Cai, et al.
Published: (2023-11-01)

Evaluation of the Cure about the Prostate Cancer Patients, Taking Radiothraphy According To the Result of the Prosecution Prostate Specific Antigen
by: Feryal Karaca, et al.
Published: (2018-10-01)

Comparative study of the values of transperineal and transrectal prostate puncture in diagnosis of prostate cancer in patients with gray/sub-gray zone of PSA
by: Wang Hailuo, Pang Kun, Wang Jingkai, Xu Peng, Xu Hao, Pan Deng, Ma Yuyang, Zhang Ruoran, Han Conghui
Published: (2024-02-01)

Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
by: Tomas Bertok, et al.
Published: (2020-10-01)

Prostate Specific Antigen Levels Among Men With Prostate Cancer in Ramadi City
by: Jalil Ibrahim Salih, et al.
Published: (2013-08-01)

Association between preoperative prostate-specific antigen levels and mortality in high- and intermediate-grade prostate cancer patients who received radical prostatectomy: Findings from the SEER database
by: Joshua Ikuemonisan, et al.
Published: (2021-06-01)

Predictive Parameters on the Effect of Ofloxacin Treatment on the Reduction of PSA in Patients With Elevated PSA Level
by: Kerem TEKE, et al.
Published: (2019-10-01)

Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer
by: Marcin Miszczyk, et al.
Published: (2022-02-01)

Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
by: Ausvydas Patasius, et al.
Published: (2020-11-01)

Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2
by: De Nitto Simone, et al.
Published: (2023-08-01)

The diagnostic value of a new formula combining age and prostate volume in prostate cancer
by: Xiaobo Yang, et al.
Published: (2022-02-01)

Illustration of association between change in prostate-specific antigen (PSA) values and time to tumor status after treatment for prostate cancer patients: a joint modelling approach
by: Madiha Liaqat, et al.
Published: (2023-12-01)

A new approach to prostate cancer screening
by: Filella Xavier, et al.
Published: (2023-08-01)

CUT-OFF VALUES OF PROSTATE SPECIFIC ANTIGEN DENSITY– AN EFFECTIVE SCREENING MARKER BEFORE PROSTATE BIOPSY
by: Zujaja Hina Haroon, et al.
Published: (2022-03-01)

Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model
by: Francesco Gentile, et al.
Published: (2021-02-01)

Application Value of Normalized Apparent Diffusion Coefficient and Prostate-specific Antigen Density for Prostate Imaging Reporting and Data System Category 3 Lesions in the Prostate-specific Antigen Gray Zone
by: Subo ZHANG, et al.
Published: (2023-01-01)

Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection
by: Dmitri Pchejetski, et al.
Published: (2023-01-01)

Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer
by: Oluwaseun Adebayo Bamodu, et al.
Published: (2021-09-01)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
by: Ebenezer Abotsi, et al.
Published: (2022-12-01)

Investigation of awareness rate of prostate-specific antigen (PSA) among the general public in China and analysis of influencing factors
by: Yuqin Wang, et al.
Published: (2023-05-01)

Risk-stratified multi-round PSA screening for prostate cancer integrating the screening reference level and subgroup-specific progression indicators
by: Xiaomin Liu, et al.
Published: (2023-07-01)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
by: Jeong Hoon Phak, et al.
Published: (2016-03-01)

Towards personalized prostate cancer screening
by: Filella Xavier
Published: (2020-01-01)

Management of a localized prostatic adenocarcinoma despite the very high rate of PSA and the large tumor mass: Does PSA level indicate the stage of prostate cancer?
by: Hammou el Farhaoui, et al.
Published: (2023-10-01)

Investigation of the Interobserver Variability of the Prostate Imaging for Recurrence Reporting (PI-RR) Score in Evaluating Local Recurrence in Prostate Cancer After Radiotherapy: Are Tumor Size and Prostate-specific Antigen Important?
by: Hüseyin Akkaya, et al.
Published: (2023-04-01)

Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
by: Zengni Ma, et al.
Published: (2023-03-01)

The Prevalence of Prostatic Cancer after Renal Transplantation
by: Mohammad Yazdani, et al.
Published: (2011-03-01)

Exposure to heavy metal elements may significantly increase serum prostate-specific antigen levels with overdosed dietary zinc
by: Yinyi Fang, et al.
Published: (2024-03-01)

Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
by: Takuya Aizawa, et al.
Published: (2023-10-01)

Prostate-specific antigen density as a proxy for predicting prostate cancer severity: Is there any difference between systematic and targeted biopsy?
by: Mostafa A Arafa, et al.
Published: (2023-01-01)

An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs
by: Muhammad Bilal, et al.
Published: (2022-12-01)

Sensitivity and specificity of prostate-specific antigen and its surrogates towards the detection of prostate cancer in sub-Saharan Africa: a systematic review with meta-analysis
by: Chika Juliet Okwor, et al.
Published: (2023-08-01)

Vitamin D, a Regulator of Androgen Levels, Is Not Correlated to PSA Serum Levels in a Cohort of the Middle Italy Region Participating to a Prostate Cancer Screening Campaign
by: Felice Crocetto, et al.
Published: (2023-02-01)